Facebook LinkedIn Twitter RSS

Merck scraps disappointing experimental cholesterol drugSource: The Associated Press

TRENTON, N.J. (AP) — Merck has decided to abandon efforts to market a closely watched experimental cholesterol medicine after mediocre test results.

Continue reading

Also Popular on LVB

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy